l 158809 has been researched along with phorbol 12,13-dibutyrate in 1 studies
| Studies (l 158809) | Trials (l 158809) | Recent Studies (post-2010) (l 158809) | Studies (phorbol 12,13-dibutyrate) | Trials (phorbol 12,13-dibutyrate) | Recent Studies (post-2010) (phorbol 12,13-dibutyrate) |
|---|---|---|---|---|---|
| 137 | 0 | 7 | 2,803 | 1 | 67 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avedanian, L; Bkaily, G; D'Orleans-Juste, P; El-Bizri, N; Gobeil, F; Hazzouri, KM; Jacques, D; Nader, M; Regoli, D; Riopel, J | 1 |
1 other study(ies) available for l 158809 and phorbol 12,13-dibutyrate
| Article | Year |
|---|---|
Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT1 and AT2 receptors.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Calcium; Calcium Signaling; Cell Nucleus; Chickens; Cytosol; Dose-Response Relationship, Drug; Heart Ventricles; Imidazoles; Indoles; Maleimides; Microscopy, Confocal; Myocytes, Cardiac; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors; Ventricular Function | 2005 |